Search research articles
Contact Us
Filters
Showing results (31-40 of 253) with videos related to
Page
of 26
Sort By:
JCO Oncology Practice
|
March 7, 2022
Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage
Pallawi Torka, Eugene Przespolewski, Andrew M Evens
Nature Clinical Practice. Oncology
|
August 6, 2008
Treatment of Hodgkin lymphoma: the past, present, and future
Andrew M Evens, Martin Hutchings, Volker Diehl
Hematology/Oncology Clinics of North America
|
November 28, 2016
Gray Zone Lymphoma: Current Diagnosis and Treatment Options
Monika Pilichowska, Athena Kritharis, Andrew M Evens
Cancer Treatment and Research
|
May 18, 2006
T-cell non-Hogdkin's lymphoma
Andrew M Evens, Christiane Querfeld, Steven T Rosen
The Lancet. Haematology
|
April 14, 2018
Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?
Kevin A David, Athena Kritharis, Andrew M Evens
Current Treatment Options in Oncology
|
January 25, 2008
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options
Kevin A David, Lauren Mauro, Andrew M Evens
Blood
|
September 15, 2021
Defining and treating high-grade B-cell lymphoma, NOS
Adam J Olszewski, Habibe Kurt, Andrew M Evens
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium
|
January 1, 1997
An empirical study of the Health Status Questionnaire System for use in patient-computer interaction
J Kim, D Trace, K Meyers, et al.
Best Practice & Research. Clinical Haematology
|
March 29, 2005
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group
Andrew M Evens, Charles L Bennett, Stefano Luminari
Bone Marrow Transplantation
|
August 3, 2004
Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress
A M Evens, J Mehta, L I Gordon
Page
of 26
Search research articles
Search
Showing results (31-40 of 253) with videos related to
Sort By:
Page
of 26
JCO Oncology Practice
|
March 7, 2022
Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage
Pallawi Torka, Eugene Przespolewski, Andrew M Evens
Nature Clinical Practice. Oncology
|
August 6, 2008
Treatment of Hodgkin lymphoma: the past, present, and future
Andrew M Evens, Martin Hutchings, Volker Diehl
Hematology/Oncology Clinics of North America
|
November 28, 2016
Gray Zone Lymphoma: Current Diagnosis and Treatment Options
Monika Pilichowska, Athena Kritharis, Andrew M Evens
Cancer Treatment and Research
|
May 18, 2006
T-cell non-Hogdkin's lymphoma
Andrew M Evens, Christiane Querfeld, Steven T Rosen
The Lancet. Haematology
|
April 14, 2018
Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?
Kevin A David, Athena Kritharis, Andrew M Evens
Current Treatment Options in Oncology
|
January 25, 2008
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options
Kevin A David, Lauren Mauro, Andrew M Evens
Blood
|
September 15, 2021
Defining and treating high-grade B-cell lymphoma, NOS
Adam J Olszewski, Habibe Kurt, Andrew M Evens
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium
|
January 1, 1997
An empirical study of the Health Status Questionnaire System for use in patient-computer interaction
J Kim, D Trace, K Meyers, et al.
Best Practice & Research. Clinical Haematology
|
March 29, 2005
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group
Andrew M Evens, Charles L Bennett, Stefano Luminari
Bone Marrow Transplantation
|
August 3, 2004
Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress
A M Evens, J Mehta, L I Gordon
Page
of 26